Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Predicting Response To Neoadjuvant Chemoradiotherapy In Esophageal Cancer With Textural Features Derived From Pretreatment 18F-FDG PET/CT Imaging

R. J. Beukinga, J. B. Hulshoff, L. V. van Dijk, C. Muijs, J. Burgerhof, G. Kats-Ugurlu, R. Slart, C. Slump, V. Mul, J. Plukker
Published 2017 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Adequate prediction of tumor response to neoadjuvant chemoradiotherapy (nCRT) in esophageal cancer (EC) patients is important in a more personalized treatment. The current best clinical method to predict pathologic complete response is SUVmax in 18F-FDG PET/CT imaging. To improve the prediction of response, we constructed a model to predict complete response to nCRT in EC based on pretreatment clinical parameters and 18F-FDG PET/CT–derived textural features. Methods: From a prospectively maintained single-institution database, we reviewed 97 consecutive patients with locally advanced EC and a pretreatment 18F-FDG PET/CT scan between 2009 and 2015. All patients were treated with nCRT (carboplatin/paclitaxel/41.4 Gy) followed by esophagectomy. We analyzed clinical, geometric, and pretreatment textural features extracted from both 18F-FDG PET and CT. The current most accurate prediction model with SUVmax as a predictor variable was compared with 6 different response prediction models constructed using least absolute shrinkage and selection operator regularized logistic regression. Internal validation was performed to estimate the model’s performances. Pathologic response was defined as complete versus incomplete response (Mandard tumor regression grade system 1 vs. 2–5). Results: Pathologic examination revealed 19 (19.6%) complete and 78 (80.4%) incomplete responders. Least absolute shrinkage and selection operator regularization selected the clinical parameters: histologic type and clinical T stage, the 18F-FDG PET–derived textural feature long run low gray level emphasis, and the CT-derived textural feature run percentage. Introducing these variables to a logistic regression analysis showed areas under the receiver-operating-characteristic curve (AUCs) of 0.78 compared with 0.58 in the SUVmax model. The discrimination slopes were 0.17 compared with 0.01, respectively. After internal validation, the AUCs decreased to 0.74 and 0.54, respectively. Conclusion: The predictive values of the constructed models were superior to the standard method (SUVmax). These results can be considered as an initial step in predicting tumor response to nCRT in locally advanced EC. Further research in refining the predictive value of these models is needed to justify omission of surgery.
This paper references
10.1148/radiol.09091324
Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review.
R. M. Kwee (2010)
10.1016/j.radonc.2015.08.031
CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
J. Honing (2015)
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
P. Therasse (2000)
10.1007/s12029-015-9699-y
Primary Gross Tumor Volume is an Important Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Trimodality Therapy
D. H. Boggs (2015)
10.2967/jnumed.114.144055
18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort
M. Hatt (2015)
10.1016/J.IJROBP.2011.06.520
Measuring Tumor Hypoxia with 18F-FETNIM PET in Esophageal Squamous Cell Carcinoma: A Pilot Clinical Study
J. Yue (2011)
10.1016/j.ijrobp.2013.09.037
Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
H. Zhang (2014)
10.1080/00031305.1976.10479172
Aesthetic Frequency Classifications
D. Doane (1976)
10.2967/jnumed.110.082404
Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
F. Tixier (2011)
10.2967/jnumed.115.163766
The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer
P. V. van Rossum (2016)
10.1109/TSMC.1973.4309314
Textural Features for Image Classification
R. Haralick (1973)
10.1007/s00259-012-2247-0
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis
S. Chicklore (2012)
10.1158/1078-0432.CCR-05-1773
Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer
J. Rajendran (2006)
EANM procedure guidelines for tumour PET imaging: version 1.0
R Boellaard (2010)
10.1016/S0146-664X(75)80008-6
Texture analysis using gray level run lengths
M. Galloway (1974)
10.1038/nrc704
Hypoxia — a key regulatory factor in tumour growth
A. Harris (2002)
10.1007/s00259-013-2486-8
Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma
M. Hatt (2013)
10.1016/j.ijrobp.2012.10.017
Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
Shan Tan (2013)
10.1109/TBME.2013.2284600
Advanced Statistical Matrices for Texture Characterization: Application to Cell Classification
G. Thibault (2014)
Prognostic significance of SUVon PET/CT in patients with esophageal cancer: a systematic review and meta-analysis
L Pan (2009)
10.1007/s00259-009-1297-4
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
R. Boellaard (2009)
10.1016/j.ijrobp.2013.11.009
Residual tumor after neoadjuvant chemoradiation outside the radiation therapy target volume: a new prognostic factor for survival in esophageal cancer.
C. Muijs (2014)
10.1200/JCO.2006.06.7801
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
K. Ott (2006)
10.1016/j.lungcan.2016.03.019
Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: Review of the literature.
A. Sindoni (2016)
10.1097/MNM.0b013e32834a8366
Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis
Y. Chen (2011)
10.1038/srep11075
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
R. Leijenaar (2015)
10.1056/NEJMoa1112088
Preoperative chemoradiotherapy for esophageal or junctional cancer.
P. V. van Hagen (2012)
10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
A. Mandard (1994)
10.1002/cncr.20916
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
L. Chirieac (2005)
10.3390/ijms13021951
Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design
S. Diaz-Cano (2012)
10.1016/j.radonc.2015.04.027
Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer.
P. V. van Rossum (2015)
10.1245/s10434-010-0985-4
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
S. Edge (2010)
10.2967/jnumed.109.072124
Measuring Tumor Cell Proliferation with 18F-FLT PET During Radiotherapy of Esophageal Squamous Cell Carcinoma: A Pilot Clinical Study
J. Yue (2010)
10.1109/TAC.1974.1100705
A new look at the statistical model identification
H. Akaike (1974)



This paper is referenced by
10.21037/JTD.2019.08.15
Role of precision imaging in esophageal cancer.
S. Elsherif (2020)
10.1016/j.ijrobp.2018.05.022
Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges.
S. Reuzé (2018)
10.21037/AOE-2020-MTEC-02
Optimization of detection of residual disease after neoadjuvant therapy in patients with esophageal cancer
Maria Valkema (2020)
10.1001/jamanetworkopen.2020.15927
Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma
Yihuai Hu (2020)
10.1016/J.MEDNUC.2017.07.008
Évaluation thérapeutique des tumeurs solides – Session 6
Ariane Girard (2017)
10.1007/s40336-018-0299-2
Heterogeneity analysis of 18F-FDG PET imaging in oncology: clinical indications and perspectives
P. Lovinfosse (2018)
10.1109/BIBE50027.2020.00127
Classification of oesophagic early-stage cancers: deep learning versus traditional learning approaches
J. Ferreira (2020)
10.1016/j.ebiom.2019.05.023
Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy
C. Xie (2019)
10.3990/1.9789036545655
Quantitative 18F-FDG PET/CT in esophageal cancer and vascular graft infections
R. J. Beukinga (2018)
10.1016/j.radonc.2020.01.027
Development and validation of a radiomics signature on differentially expressed features of 18F-FDG PET to predict treatment response of concurrent chemoradiotherapy in thoracic esophagus squamous cell carcinoma.
Q. Cao (2020)
10.21037/jtd.2017.09.117
Editorial on "Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer".
C. Liu (2017)
10.1007/s00259-019-04306-7
Exploratory radiomic features from integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer
Serena Baiocco (2019)
Towards a more personalized approach in the treatment of esophageal cancer focusing on predictive factors in response to chemoradiation
D. Wang (2017)
10.1007/s00259-017-3742-0
Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy
Sebastian Zschaeck (2017)
10.1016/j.ejso.2018.11.002
A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy.
Z. Faiz (2019)
10.4172/2161-0932.S5:010
Measuring Intratumoral Metabolic Heterogeneity by Positron Emission Tomography in Cervical Cancer–A Review
Yun Tang (2017)
10.1038/s41598-018-37197-z
A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
S. Milgrom (2019)
10.31557/APJCP.2019.20.7.2003
Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using 18FDG PET/CT with Standardized Protocol
Nosheen Fatima (2019)
10.3760/CMA.J.ISSN.0254-5098.2018.03.015
Progress on application of radiomics in radiotherapy of esophageal cancer
Zhen Hou (2018)
10.3389/fonc.2020.599907
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
N. Simoni (2020)
10.35712/aig.v1.i2.37
Diagnostic advances of artificial intelligence and radiomics in gastroenterology
Pei Feng (2020)
10.1007/s00259-020-05142-w
Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment
Nina J. Wesdorp (2020)
10.2967/jnumed.117.199935
A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET
F. Orlhac (2018)
10.1097/MNM.0000000000000917
Modified fractal analysis of methionine positron emission tomography images for predicting prognosis in newly diagnosed patients with glioma
Reiko Nakajima (2018)
Aplicaciones del PET/CT en oncología
J. González (2017)
10.1007/s00261-018-1724-8
Radiomics in esophageal and gastric cancer
B. Sah (2018)
10.1097/MNM.0000000000000860
Integrated texture parameter of 18F-FDG PET may be a stratification factor for the survival of nonoperative patients with locally advanced non-small-cell lung cancer
W. Liu (2018)
10.1007/s00330-019-06074-2
Can pretreatment 18F-FDG PET tumor texture features predict the outcomes of osteosarcoma treated by neoadjuvant chemotherapy?
H. Song (2019)
10.23736/S1824-4785.19.03213-8
Machine learning for radiomics-based multi-modality and multi-parametric modeling.
Lise Wei (2019)
10.1109/ACCESS.2019.2930891
Computer Vision in Esophageal Cancer: A Literature Review
Inês Domingues (2019)
10.1016/j.ijrobp.2017.12.268
Challenges and Promises of PET Radiomics
G. Cook (2018)
10.1016/j.radonc.2019.10.012
Heterogeneity in tumours: Validating the use of radiomic features on 18F-FDG PET/CT scans of lung cancer patients as a prognostic tool.
Marie Manon Krebs Krarup (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar